{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T14:26:39Z","timestamp":1720016799616},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ricerca Corrente 2016 (Ministry of Health) of IRCCS Istituto Tumori Giovanni Paolo II, Bari-Italy"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.canlet.2018.12.013","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T22:29:20Z","timestamp":1545431360000},"page":"1-10","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Synthesis and biological evaluation of N-biphenyl-nicotinic based moiety compounds: A new class of antimitotic agents for the treatment of Hodgkin Lymphoma"],"prefix":"10.1016","volume":"445","author":[{"given":"L.","family":"Porcelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Stolfa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Stefanachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Di Fonte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Garofoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.M.","family":"Iacobazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Silvestris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Guarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Cellamare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Azzariti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2018.12.013_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.148","article-title":"Mitosis-targeted anti-cancer therapies: where they stand","volume":"3","author":"Chan","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2018.12.013_bib2","first-page":"229","article-title":"Bcl2 is the guardian of microtubule integrity","volume":"57","author":"Haldar","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2018.12.013_bib3","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1021\/jm201305y","article-title":"Potent galloyl-based selective modulators targeting multidrug resistance associated protein 1 and P-glycoprotein","volume":"55","author":"Pellicani","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.canlet.2018.12.013_bib4","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1021\/jm500697c","article-title":"Trimethoxybenzanilide-based P-glycoprotein modulators: an interesting case of lipophilicity tuning by intramolecular hydrogen bonding","volume":"57","author":"Tardia","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.canlet.2018.12.013_bib5","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/cmdc.201700365","article-title":"Investigating structural requirements for the antiproliferative activity of biphenyl nicotinamides","volume":"12","author":"Majellaro","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.canlet.2018.12.013_bib6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1515\/hsz-2017-0321","article-title":"Hodgkin lymphoma cell lines: to separate the wheat from the chaff","volume":"399","author":"Drexler","year":"2018","journal-title":"Biol. Chem."},{"key":"10.1016\/j.canlet.2018.12.013_bib7","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2174\/1389450116666141205145620","article-title":"The EGFR pathway regulates BCRP expression in NSCLC cells: role of erlotinib","volume":"15","author":"Porcelli","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.canlet.2018.12.013_bib8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.bcp.2008.10.036","article-title":"TGF\u03b21 antagonistic peptides inhibit TGF\u03b21-dependent angiogenesis","volume":"77","author":"Serrat\u00ec","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2018.12.013_bib9","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1091\/mbc.e16-08-0567","article-title":"Mechanisms of kinetic stabilization by the drugs paclitaxel and vinblastine","volume":"28","author":"Castle","year":"2017","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.canlet.2018.12.013_bib10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature09779","article-title":"Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7","volume":"471","author":"Wertz","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2018.12.013_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bcp.2011.10.008","article-title":"Cdk1\/cyclin B plays a key role in mitotic arrest-induced apoptosis by phosphorylation of Mcl-1, promoting its degradation and freeing Bak from sequestration","volume":"83","author":"Chu","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2018.12.013_bib12","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1128\/MCB.22.11.3577-3589.2002","article-title":"Identification of novel isoforms of the BH3 domain protein Bim which directly activate Bax to trigger apoptosis","volume":"22","author":"Marani","year":"2002","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2018.12.013_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1158\/1535-7163.MCT-13-0791","article-title":"Targeting microtubules by natural agents for cancer therapy","volume":"13","author":"Mukhtar","year":"2014","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.canlet.2018.12.013_bib14","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1128\/MCB.00882-09","article-title":"Cyclin-dependent kinase 1-mediated bcl-xL\/bcl-2 phosphorylation acts as a functional link coupling mitotic arrest and apoptosis","volume":"30","author":"Terrano","year":"2010","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2018.12.013_bib15","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.4161\/cc.10.22.18020","article-title":"Cyclin B1 interacts with the BH3-only protein Bim and mediates its phosphorylation by Cdk1 during mitosis","volume":"10","author":"Mac Fhearraigh","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2018.12.013_bib16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s10495-013-0928-1","article-title":"Prometaphase arrest-dependent phosphorylation of Bcl-2 and Bim reduces the association of Bcl-2 with Bak or Bim, provoking Bak activation and mitochondrial apoptosis in nocodazole-treated Jurkat T cells","volume":"19","author":"Han","year":"2014","journal-title":"Apoptosis"},{"key":"10.1016\/j.canlet.2018.12.013_bib17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/344503a0","article-title":"Universal control mechanism regulating onset of M-phase","volume":"344","author":"Nurse","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2018.12.013_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/35048096","article-title":"Mitotic kinases as regulators of cell division and its checkpoints","volume":"2","author":"Nigg","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2018.12.013_bib19","doi-asserted-by":"crossref","first-page":"R787","DOI":"10.1016\/j.cub.2004.09.020","article-title":"APC\/C and SCF: controlling each other and the cell cycle","volume":"14","author":"Vodermaier","year":"2004","journal-title":"Curr. Biol."},{"key":"10.1016\/j.canlet.2018.12.013_bib20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1097-2765(00)80456-6","article-title":"The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex","volume":"3","author":"Puthalakath","year":"1999","journal-title":"Mol. Cell."},{"key":"10.1016\/j.canlet.2018.12.013_bib21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/sj.onc.1208189","article-title":"Characterization of vinblastine-induced Bcl-xL and Bcl-2 phosphorylation: evidence for a novel protein kinase and a coordinated phosphorylation\/dephosphorylation cycle associated with apoptosis induction","volume":"24","author":"Du","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2018.12.013_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000095558","article-title":"Pathobiology of classical Hodgkin lymphoma","volume":"73","author":"Tzankov","year":"2006","journal-title":"Pathobiology"},{"key":"10.1016\/j.canlet.2018.12.013_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.humpath.2006.06.017","article-title":"Expression of bcl2 family proteins and active caspase 3 in classical Hodgkin's lymphomas","volume":"38","author":"Bai","year":"2007","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.canlet.2018.12.013_bib24","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1080\/10428190902943069","article-title":"Targeting the Bcl-2 family of proteins in Hodgkin lymphoma: in vitro cytotoxicity, target modulation and drug combination studies of the Bcl-2 homology 3 mimetic ABT-737","volume":"50","author":"Jayanthan","year":"2009","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.canlet.2018.12.013_bib25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.drup.2006.04.003","article-title":"Microtubule-targeting agents in angiogenesis: where do we stand?","volume":"9","author":"Pasquier","year":"2006","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.canlet.2018.12.013_bib26","doi-asserted-by":"crossref","first-page":"14325","DOI":"10.18632\/oncotarget.9527","article-title":"Antivascular and antitumor properties of the tubulin-binding chalcone TUB091","volume":"8","author":"Canela","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2018.12.013_bib27","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1096\/fasebj.14.5.652","article-title":"Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line","volume":"14","author":"Biroccio","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.canlet.2018.12.013_bib28","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1158\/0008-5472.CAN-05-0140","article-title":"Bcl-2 acts in a proangiogenic signaling pathway through nuclear factor-\u03baB and CXC chemokines","volume":"65","author":"Karl","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2018.12.013_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11060-008-9602-9","article-title":"Expression of bcl-2 is associated with microvessel density in olfactory neuroblastoma","volume":"89","author":"Diensthuber","year":"2008","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.canlet.2018.12.013_bib30","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/jnci\/93.3.208","article-title":"Angiogenic potential of prostate carcinoma cells overexpressing bcl-2","volume":"93","author":"Fernandez","year":"2001","journal-title":"J. Natl. Cancer Inst."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383518307286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383518307286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T23:49:14Z","timestamp":1548114554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383518307286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":30,"alternative-id":["S0304383518307286"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2018.12.013","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of N-biphenyl-nicotinic based moiety compounds: A new class of antimitotic agents for the treatment of Hodgkin Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2018.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}